Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

PHENYTOIN REDUCES ACTIVITY OF RYR2 - A POTENTIAL MECHANISM FOR ITS CARDIOPROTECTIVE ACTION

Amir Ashna, Dirk Van Helden, Cris dos Remedios, Peter Molenaar and Derek Laver
Molecular Pharmacology February 3, 2020, mol.119.117721; DOI: https://doi.org/10.1124/mol.119.117721
Amir Ashna
1 University of Newcastle;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dirk Van Helden
1 University of Newcastle;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cris dos Remedios
2 University of Sydney;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Molenaar
3 Queensland Univeristy of Technology;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Derek Laver
4 Universith opf Newcastle
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

mol.119.117721
DOI 
https://doi.org/10.1124/mol.119.117721
PubMed 
32015008

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online February 3, 2020.

Article Versions

  • You are currently viewing an Earlier version of this article (February 3, 2020 - 05:05).
  • View the most recent version of this article
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Amir Ashna1,
  2. Dirk Van Helden1,
  3. Cris dos Remedios2,
  4. Peter Molenaar3, and
  5. Derek Laver4,*
  1. 1 University of Newcastle;
  2. 2 University of Sydney;
  3. 3 Queensland Univeristy of Technology;
  4. 4 Universith opf Newcastle
  1. ↵*Address correspondence to: derek.laver{at}newcastle.edu.au

Statistics from Altmetric.com

Article usage

Article usage: February 2020 to March 2023

AbstractFullPdf
Feb 2020502989
Mar 20202322226
Apr 2020811014
May 2020751319
Jun 20201302015
Jul 20203058
Aug 20204589
Sep 2020541310
Oct 20203746
Nov 20203086
Dec 202048310
Jan 20215014
Feb 202157512
Mar 2021102613
Apr 202142724
May 2021758932
Jun 2021481614
Jul 2021864617
Aug 202145316
Sep 202135558
Oct 2021102535
Nov 202184147
Dec 2021133123
Jan 202264922
Feb 202253115
Mar 202245818
Apr 2022106210
May 202244419
Jun 202243624
Jul 2022176234
Aug 2022105016
Sep 202262522
Oct 202252313
Nov 202234720
Dec 202223512
Jan 202323510
Feb 20233649
Mar 20233443

Next
Back to top

In this issue

Molecular Pharmacology: 103 (4)
Molecular Pharmacology
Vol. 103, Issue 4
1 Apr 2023
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
PHENYTOIN REDUCES ACTIVITY OF RYR2 - A POTENTIAL MECHANISM FOR ITS CARDIOPROTECTIVE ACTION
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

PHENYTOIN REDUCES ACTIVITY OF RYR2 - A POTENTIAL MECHANISM FOR ITS CARDIOPROTECTIVE ACTION

Amir Ashna, Dirk Van Helden, Cris dos Remedios, Peter Molenaar and Derek Laver
Molecular Pharmacology February 3, 2020, mol.119.117721; DOI: https://doi.org/10.1124/mol.119.117721

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

PHENYTOIN REDUCES ACTIVITY OF RYR2 - A POTENTIAL MECHANISM FOR ITS CARDIOPROTECTIVE ACTION

Amir Ashna, Dirk Van Helden, Cris dos Remedios, Peter Molenaar and Derek Laver
Molecular Pharmacology February 3, 2020, mol.119.117721; DOI: https://doi.org/10.1124/mol.119.117721
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics